|
Established
2000
|
Franchise Started
2000
|
Owned Outlets
3
|
Franchise Outlets
490
|
Investment
₹5 Cr+
|
Brand Profile
Solace Biotech Limited is a rising star in India's pharmaceutical Industry having pharma franchise associates across India providing qualitative products with an unbelievable offers.
Single Unit Investment for SOLACE BIOTECH
| Sl | Heading | Description |
|---|---|---|
| 1 | Expected Investment | ₹5 Cr+ |
| 2 | Investments Includes |
Franchise Fee
Equipments Furniture and Fixtures Advertising / Marketing |
| 3 | Capital Investment | |
| 4 | Expected Payback Period | |
| 5 | Expected ROI |
Master Franchise Investment for SOLACE BIOTECH
| Sl | Heading | Description |
|---|---|---|
| 1 | Expected Investment | |
| 2 | Franchise Fee | |
| 3 | Investments Includes |
Furniture and Fixtures
Advertising / Marketing: 25000 |
| 4 | Capital Investment |
Important Points for SOLACE BIOTECH Franchise
| Sl | Heading | Description |
|---|---|---|
| 1 | Franchise Training Program |
Training Program available for the franchisee
Software-Hardware Support included in the Franchise Fees |
| 2 | Franchise Training Venue | Head Office |
| 3 | Franchise available in Regions |
Central
Eastern Northern Southern Western North-East All India |
| 4 | Area/Site Preference | |
| 5 | Minimum Floor Area needed | |
| 6 | Term of Franchise Agreement |
Franchise Agreement is renewable
|
| 7 | Other Important Points |
Minimum Guarantee given
Facility provided Master Franchise Available Site Select Help given |
Frequently Asked Questions — SOLACE BIOTECH Franchise
The expected investment for a SOLACE BIOTECH franchise is ₹5 Cr+. This includes franchise fee, equipment, furniture & fixtures, advertising & marketing.
SOLACE BIOTECH provides a training program for franchisees conducted at the Head Office.
Currently, SOLACE BIOTECH does not list a Master Franchise opportunity. Single-unit franchise is available.
SOLACE BIOTECH operates in the Health Care sector. It is listed on Franchisezing under Health Care franchise opportunities in India.